Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

BIIL-284: a potent, orally active LTB4 antagonist with promise in inflammatory diseases

June 1, 2001

Rigel boosts IgE receptor regulation program for asthma/allergy

June 1, 2001

Synthetic fragment of secreted human peptide inhibits IL-8-induced nasal inflammation

June 1, 2001

Protherics designs new tryptase inhibitors particularly useful in asthma Rx

May 31, 2001

Purine derivatives identified as adenosine A2A agonists at Pfizer

May 31, 2001

ATS 2001: preclinical and clinical findings support development of roflumilast in asthma, COPD

May 31, 2001

Recombinant AAT closer to obtaining orphan drug designation in E.U.

May 30, 2001

Novartis launches Foradil Aerolizer in the U.S.

May 30, 2001

Potent, selective, second-generation PDE4 inhibitor with improved safety profile

May 28, 2001

ATS 2001: JNK inhibitors as next-generation compounds for asthma

May 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...